Navigation Links
Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate
Date:12/10/2007

Datascope Receives a Split-Vote Recommendation From One Proxy Advisory Firm

MONTVALE, N.J., Dec. 10 /PRNewswire-FirstCall/ -- Datascope Corp. (Nasdaq: DSCP) today issued a statement strongly recommending shareholders re-elect Datascope's two incumbent nominees - James J. Loughlin and William L. Asmundson - and reject Ramius Capital's opposition slate in connection with the Company's December 20, 2007 Annual Meeting of Shareholders.

Robert Klatell, Chairman of Datascope's Nominations and Corporate Governance Committee, stated, "We have the right Board of Directors in place with the right balance of experience, tenure and skills that are critical to the Company's continued success. Our two nominees for re-election - James J. Loughlin and William L. Asmundson - provide strong leadership and sound guidance, as outside directors in critical roles on Datascope's seven person Board. They are clearly the most qualified and best candidates to serve all our shareholders on the Company's Board. We strongly urge shareholders to reject the dissident candidates and re-elect our incumbent directors."

Mr. Klatell emphasized, "I am extremely proud to serve with these individuals and the other members of Datascope's Board:

-- James Loughlin joined the Board for the first time in 2004 and became

Chairman of the Audit Committee and its financial expert under SEC

rules. He also serves as a member of the Compensation Committee. Jim

brings an extremely relevant background to Datascope from his

accomplishments during over 40 years at KPMG, one of the world's major

accounting firms. At KPMG he chaired its Life Science and

Pharmaceuticals practices and led i
'/>"/>

SOURCE Datascope Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Datascope Mails Letter to Shareholders
2. Datascope Files Investor Presentation
3. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
4. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
5. American College of Physicians recommends flu vaccination for health-care workers
6. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
7. FDA Panel Recommends Ban on Cold Medicines for Kids
8. AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies
9. National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning
10. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
11. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Braintree, Massachusetts (PRWEB) July 28, 2014 ... the Summit Provider Exchange technology solution ... office integration efforts and support collaboration with their ... 242 bed acute-care medical center located in New ... 800,000 seasonal visitors with a variety of inpatient ...
(Date:7/28/2014)... News) -- Endurance runners are far more likely to ... according to a new study. The researchers ... warm climates are actually 10 times more likely to ... common sudden death of a young and apparently healthy ... irregular heartbeat, often gets a lot more media attention. ...
(Date:7/28/2014)... July 28, 2014 The Oakwood Foundation ... Birkhill, Wang, Songe and Associates, PC that will benefit ... tomorrows to come. , The HBWS group is ... more than $2.5 million in donations. Through their latest ... for the Oakwood Women’s Healthcare Classic for the next ...
(Date:7/28/2014)... regions in the brain was able to arouse animals ... In the August issue of Anesthesiology , investigators ... with continuous doses of either agent would move, raise ... electrical stimulation delivered to the ventral tegmental area (VTA). ... substantia nigra, did not induce the animals to wake ...
(Date:7/28/2014)... The report, “Blowing Agents Market by Type, ... Forecasts to 2019” defines and segments the global ... the global consumption volume and value. , Browse ... figures spread through 226 Pages and in-depth TOC ... Blowing agents are highly utilized materials as a ...
Breaking Medicine News(10 mins):Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4
... plans are partnering with physician practices to initiate a range ... these programs have resulted in decreased emergency room (ER) use, ... by the Alliance of Community Health Plans (ACHP), are part ... way community health plans partner with providers to improve care. ...
... Risk Factors for,Developing MS, UB Study Shows, ... insufficiency (CCSVI), which has attracted global attention as possibly being ... for the presence of risk factors in subjects who do ... study of 252 volunteers has found an association between CCSVI ...
... HealthDay Reporter , WEDNESDAY, Nov. 30 (HealthDay News) ... drink or doing some last-minute grooming, a large majority of ... distracted while behind the wheel, a new poll shows. ... adults who drive on a regular basis admitted to having ...
... health care workers at risk of 2009 H1N1 infection during ... according to a study published in the December issue of ... the Society of Healthcare Epidemiology of America. ... Prevention (CDC), tracked 63 Southern California health care workers who ...
... , WEDNESDAY, Nov. 30 (HealthDay News) -- Women ... those with other forms of breast cancer to have a ... finds. Swedish researchers examined the family history, pathology reports ... 1980 and 2008. About 40 percent of the women had ...
... About 40 percent of young adults who,ve attempted suicide made ... thoughts and behavior may begin much younger than previously believed, ... ongoing survey, University of Washington researchers asked almost 900 young ... attempts. Nearly 9 percent (78) of the participants said ...
Cached Medicine News:Health News:New report: Community health plans improving care for patients with chronic illnesses 2Health News:New report: Community health plans improving care for patients with chronic illnesses 3Health News:Risk factors for CCSVI are similar to risk factors for developing MS, UB study shows 2Health News:Risk factors for CCSVI are similar to risk factors for developing MS, UB study shows 3Health News:Risk factors for CCSVI are similar to risk factors for developing MS, UB study shows 4Health News:Most U.S. Drivers Engage in 'Distracting' Behaviors: Poll 2Health News:Most U.S. Drivers Engage in 'Distracting' Behaviors: Poll 3Health News:Most U.S. Drivers Engage in 'Distracting' Behaviors: Poll 4Health News:Lobular Breast Cancer Linked to Paternal Cancer History 2Health News:Many Suicidal Teens Make First Try Before High School 2
(Date:7/28/2014)... 2,500 scientists and experts from around the world will ... for the largest international meeting of the year devoted ... fields as far flung as genomics and geology who ... processes to creating life-saving drugs. This meeting ... has declared 2014 the International Year of Crystallography (IYCr2014) ...
(Date:7/28/2014)... Va. , July 28, 2014  Serco ... services, announced the Company has been awarded a ... Support Command (NEMSCOM) and its Deployable Medical Systems.  ... enable medical personnel to provide world-class healthcare to ... operating environment across the globe. The five year ...
(Date:7/28/2014)...  UBM Medica US announces that Diagnostic ... imaging professionals, explored the complex situation regarding measuring ... The shift from fee-for-service has left radiology at ... is determined in the new payment model . ... field, who recognized the complexity of the radiologist,s value: ...
Breaking Medicine Technology:All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 2All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 3All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 4All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 6Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2Diagnostic Imaging Delves into Measuring the Radiologist's Value 2
... ... today that new data, including a late-breaking presentation on Tasigna® ... leukemia, demonstrate the strength of the company,s hematology portfolio in ... at the 51st American Society of Hematology (ASH) Annual Meeting ...
... 1 Patient Safety Technologies, Inc. (OTC Bulletin Board: ... Rose, CPA(PA), to the position of Chief Financial Officer, ... has been acting CFO since 2008. Prior to ... President Finance, Chief Financial Officer, Treasurer and Corporate Secretary ...
Cached Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: